Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review

This publication has 55 references indexed in Scilit:

• Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
  Journal of Thoracic Oncology, 2011
• Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non–small cell lung cancer: Results from a multicenter phase III study
  The Journal of Thoracic and Cardiovascular Surgery, 2011
• A survey of stereotactic body radiotherapy use in the United States
  Cancer, 2011
• CyberKnife for hilar lung tumors: report of clinical response and toxicity
  Journal of Hematology & Oncology, 2010
• Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
  Radiation Oncology, 2010
• Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus
  Lung Cancer, 2009
• Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis
  Radiotherapy and Oncology, 2009
• Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study
  Radiation Oncology, 2009
• Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
  Journal of Clinical Oncology, 2008
• Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose
  Radiation Oncology, 2008